CEP-33779是一种新型的口服活性JAK2选择性抑制剂，用于自身反应性浆细胞的消耗和小鼠狼疮性肾炎的治疗

{"title":"CEP-33779是一种新型的口服活性JAK2选择性抑制剂，用于自身反应性浆细胞的消耗和小鼠狼疮性肾炎的治疗","authors":"R. Panush","doi":"10.1016/J.YMED.2012.09.029","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23907,"journal":{"name":"Yearbook of Medicine","volume":"3 1","pages":"18"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2\",\"authors\":\"R. Panush\",\"doi\":\"10.1016/J.YMED.2012.09.029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23907,\"journal\":{\"name\":\"Yearbook of Medicine\",\"volume\":\"3 1\",\"pages\":\"18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Yearbook of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.YMED.2012.09.029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YMED.2012.09.029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}